INSUBCONTINENT EXCLUSIVE:
WASHINGTON - A US government-convened expert committee on Friday voted against recommending the approval of the first new Alzheimer's drug
in almost two decades after finding insufficient evidence of its benefit.
ImageCredits: Bangkok Post
